Last reviewed · How we verify
NCT06320132: BLANDISH
BLANDISH (Brain, Loss of Function, Aneurism, Disease, Injury, Stroke, Hemorrhage)
trial testing Treatment of spontaneous intracranial hemorrhage in Intracranial Hemorrhages in 2,000 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | IRCCS Ospedale San Raffaele |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 13 March 2024 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 January 2029 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Treatment of spontaneous intracranial hemorrhage
Conditions studied
- Intracranial Hemorrhages — all drugs for Intracranial Hemorrhages →
Sponsor
IRCCS Ospedale San Raffaele — full company profile →
Who can join
18 and older, any sex, with Intracranial Hemorrhages. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to train a machine learning system based on data from patients affected by spontaneous Intracranial Hemorrage. The main question it aims to answer is whether there is a correlation between actual clinical pratice, reached outcomes and favorable or unfavorable predictive factors, and anamnesis. Participants will be treated as per standard clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06320132
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracranial Hemorrhages
Currently open trials in the same condition.
- NCT06878066 — Thrombolysis in Factor Xa-inhibitors Trial · Phase 3 · recruiting
- NCT07175519 — Safety and Efficacy of Aneurysms Treated With Endovascular Devices · recruiting
- NCT06632587 — Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes · NA · recruiting
- NCT06635564 — Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics · recruiting
- NCT06404645 — A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma · recruiting
Other IRCCS Ospedale San Raffaele trials
Trials by the same sponsor.
- NCT07530107 — Observational, Retrospective, Single-center Study Aimed at Evaluating Long-term Outcomes Following Transvenous Lead Extr · not yet recruiting
- NCT07171905 — CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease · Phase 2 · recruiting
- NCT07275099 — Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome. · not yet recruiting
- NCT06896305 — Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Rando · NA · recruiting
- NCT06667128 — Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart F · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06320132 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Ospedale San Raffaele
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06320132.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing